CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia

被引：0
|
作者：
Na Yang
Caili Zhang
Yingchun Zhang
Yuting Fan
Jing Zhang
Xiaojin Lin
Ting Guo
Yangzuo Gu
Jieheng Wu
Jianmei Gao
Xing Zhao
Zhixu He
机构：
[1] Guizhou Medical University (GMU),Tissue Engineering and Stem Cell Experiment Center
[2] Guizhou Medical University,Department of Immunology, College of Basic Medical Sciences
[3] Guizhou Medical University,Department of Biology, School of Basic Medical Sciences
[4] the Affiliated Hospital of Guizhou Medical University,Department of Gynecology
[5] Sichuan University,State Key Laboratory of Biotherapy and Cancer Center
[6] Zunyi Medical University,School of Pharmacy
[7] Chinese Academy of Medical Sciences),Key Laboratory of Adult Stem Cell Translational Research
[8] the Affiliated Hospital of Zunyi Medical University,Department of Pediatrics
来源：
Journal of Translational Medicine | / 22卷
关键词：
Chimeric antigen receptor; Natural killer cells; Dual targets; mRNA; Acute lymphoblastic leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia
    Delgado, Julio
    Caballero-Banos, Miguel
    Ortiz-Maldonado, Valentin
    Castella, Maria
    Magnano, Laura
    Juan, Manel
    Urbano-Ispizua, Alvaro
    HEMASPHERE, 2019, 3 (02):
  • [42] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS TARGETING THE CD19 ANTIGEN FOR THE TREATMENT OF RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
    Curran, Kevin
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
  • [43] Chimeric Antigen Receptor-Engineered NK Cells Overcome CD226 Downregulation As an Immune Escape Mechanism in Acute Myeloid Leukemia
    Garcia, Luciana Melo
    Gangadharan, Achintyan
    Banerjee, Pinaki
    Lin, Paul
    Daher, May
    Rafei, Hind
    Kumar, Bijender
    Rezvani, Katayoun
    BLOOD, 2023, 142
  • [44] CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphoma
    Schomer, Nathan T.
    Jiang, Ziyue Karen
    Lloyd, Marit I.
    Klingemann, Hans
    Boissel, Laurent
    CYTOTHERAPY, 2022, 24 (08) : 827 - 834
  • [45] The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL)
    Maude, Shannon L.
    Hucks, George E.
    Self, Alix Eden
    Talekar, Mala Kiran
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Gupta, Minna
    Frey, Noelle V.
    Porter, David L.
    Levine, Bruce L.
    Melenhorst, Jan J.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] CD19/CD20 bispecific chimeric antigen receptor (CAR) in naive/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma
    Larson, Sarah Marie
    Walthers, Christopher
    Ji, Brenda
    Ghafouri, Sanaz N.
    Naparstek, Jacob
    Trent, Jacqueline
    Harris, Caitlin
    Gandhi, Mobina Khericha
    Schweppe, Thomas
    Auerbach, Martin S.
    Said, Jonathan W.
    Nawaly, Karla
    Mead, Monica Diane
    De Vos, Sven
    Young, Patricia
    Oliai, Caspian
    Schiller, Gary J.
    Timmerman, John
    Ribas, Antoni
    Chen, Yvonne Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] CD19 Directed Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
    Anagnostou, Theodora
    Bin Riaz, Irbaz
    Hashmi, Shahrukh K.
    Murad, Mohammad Hassan
    Kenderian, Saad S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [48] Phase 1 Results of CNCT19: CD19 CAR Constructed of a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Xu, Yingxi
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    BLOOD, 2019, 134
  • [49] A Novel Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD123 to Treat Relapsed Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Tu, Sanfang
    Deng, Lan
    Huang, Rui
    Zhou, Xuan
    Yang, Jilong
    Zhou, Weijun
    Li, Meifang
    Yue, Chunyan
    Wu, Shaojie
    Guo, Zhenling
    Chang, Lung-Ji
    Li, Yuhua
    BLOOD, 2018, 132
  • [50] CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
    Hu, Yongxian
    Zhou, Yali
    Zhang, Mingming
    Ge, Wengang
    Li, Yi
    Yang, Li
    Wei, Guoqing
    Han, Lu
    Wang, Hao
    Yu, Shuhui
    Chen, Yi
    Wang, Yanbin
    He, Xiaohong
    Zhang, Xingwang
    Gao, Ming
    Yang, Jingjing
    Li, Xiuju
    Ren, Jiangtao
    Huang, He
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2764 - 2772
12345